Environmental monitoring in stem cell banks

被引:12
作者
Cobo, Fernando
Stacey, Glyn N.
Cortes, Jose Luis
Concha, Angel
机构
[1] Univ Granada, Hosp Virgen Nieves, Stem Cell Bank Andalucia, Spanish Cent Node, E-18014 Granada, Spain
[2] Natl Inst Biol Stand & Controls, UK Stem Cell Bank, Potters Bar EN6 3QG, Herts, England
基金
英国医学研究理事会;
关键词
D O I
10.1007/s00253-006-0326-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The processing of stem cell lines for application in human therapy requires a physical environment in which air quality (i.e., the number of airborne particles) is controlled to minimize risk of contamination. The processing facility should be constructed and operated to minimise the introduction, generation and retention of particles and microorganisms. A formal program of environmental monitoring should be maintained in each stem cell bank to specify and assess key factors and their influence on the microbiological quality of the process and product. This program should assure the manipulation of cells involved in the derivation of stem cell lines and their culture under established limits for airborne particles and for microbial contamination of the air and surfaces. Environmental monitoring should also address the regulatory requirements in the countries in which the cells will be used. The monitoring programme will depend on local conditions in each processing centre or cell bank. Each centre will need to evaluate its specific needs and establish appropriate monitoring procedures which should not become intrusive to the extent that they might compromise the quality of the cell banks or products.
引用
收藏
页码:651 / 662
页数:12
相关论文
共 52 条
[1]  
[Anonymous], 2004, EUROPEAN PHARMACOPOE
[2]   Spread of coagulase-negative staphylococci during cardiac operations in a modem operating room [J].
Bitkover, CY ;
Marcusson, E ;
Ransjö, U .
ANNALS OF THORACIC SURGERY, 2000, 69 (04) :1110-1115
[3]  
BOOTH A, 2003, ENV MONITORING PRACT, P48
[4]  
*BRIT STAND I, 2000, 12469 BS EN BRIT STA
[5]   Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases [J].
Bunnell, BA ;
Deng, WW ;
Robinson, CM ;
Waldron, PR ;
Bivalacqua, TJ ;
Baber, SR ;
Hyman, AL ;
Kadowitz, PJ .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2005, 83 (07) :529-539
[6]   Cryopreservation, thawing, and transfer of human embryos [J].
Byrd, W .
SEMINARS IN REPRODUCTIVE MEDICINE, 2002, 20 (01) :37-43
[7]  
Coecke S., 2005, ATLA-ALTERN LAB ANIM, V33, P1
[8]  
CUMITECH LL, 1980, PRACTICAL METHODS CU
[9]  
CUNDELL AM, 2004, PHARM TECHNOLOGY JUN, P56
[10]  
CURRAN A, 1998, SAFETY CELL TISSUE C, P116